<HashMap><database>biostudies-literature</database><scores/><additional><omics_type>Unknown</omics_type><volume>9(11)</volume><submitter>Ali D</submitter><pubmed_abstract>&lt;h4>Aims&lt;/h4>There has been a paradigm shift proposing that comorbidities are a major contributor towards the heart failure with preserved ejection fraction (HFpEF) syndrome. Furthermore, HFpEF patients have abnormal macrovascular and microvascular function, which may significantly contribute towards altered ventricular-vascular coupling in these patients. The IDENTIFY-HF study will investigate whether gradually increased arterial stiffness (in addition to ageing) as a result of increasing common comorbidities, such as hypertension and diabetes, is associated with HFpEF.&lt;h4>Methods and analysis&lt;/h4>In our observational study, arterial compliance and microvascular function will be assessed in five groups (Groups A to E) of age, sex and body mass index matched subjects (age ≥70 years in all </pubmed_abstract><journal>BMJ open</journal><pagination>e027984</pagination><full_dataset_link>https://www.ebi.ac.uk/biostudies/studies/S-EPMC6886989</full_dataset_link><repository>biostudies-literature</repository><pubmed_title>Heart failure with preserved ejection fraction (HFpEF) pathophysiology study (IDENTIFY-HF): does increased arterial stiffness associate with HFpEF, in addition to ageing and vascular effects of comorbidities? Rationale and design.</pubmed_title><pmcid>PMC6886989</pmcid><pubmed_authors>Ennis S</pubmed_authors><pubmed_authors>McGuire S</pubmed_authors><pubmed_authors>Ali D</pubmed_authors><pubmed_authors>Weickert MO</pubmed_authors><pubmed_authors>Cappuccio FP</pubmed_authors><pubmed_authors>Powell R</pubmed_authors><pubmed_authors>Miller MA</pubmed_authors><pubmed_authors>McGregor G</pubmed_authors><pubmed_authors>Callan N</pubmed_authors><pubmed_authors>Banerjee P</pubmed_authors></additional><is_claimable>false</is_claimable><name>Heart failure with preserved ejection fraction (HFpEF) pathophysiology study (IDENTIFY-HF): does increased arterial stiffness associate with HFpEF, in addition to ageing and vascular effects of comorbidities? Rationale and design.</name><description>&lt;h4>Aims&lt;/h4>There has been a paradigm shift proposing that comorbidities are a major contributor towards the heart failure with preserved ejection fraction (HFpEF) syndrome. Furthermore, HFpEF patients have abnormal macrovascular and microvascular function, which may significantly contribute towards altered ventricular-vascular coupling in these patients. The IDENTIFY-HF study will investigate whether gradually increased arterial stiffness (in addition to ageing) as a result of increasing common comorbidities, such as hypertension and diabetes, is associated with HFpEF.&lt;h4>Methods and analysis&lt;/h4>In our observational study, arterial compliance and microvascular function will be assessed in five groups (Groups A to E) of age, sex and body mass index matched subjects (age ≥70 years in all </description><dates><release>2019-01-01T00:00:00Z</release><publication>2019 Nov</publication><modification>2026-05-07T06:41:56.471Z</modification><creation>2020-05-21T20:31:46Z</creation></dates><accession>S-EPMC6886989</accession><cross_references><pubmed>31748285</pubmed><doi>10.1136/bmjopen-2018-027984</doi></cross_references></HashMap>